Predicting Patterns of Long-Term CD4 Reconstitution in HIV-Infected Children Starting Antiretroviral Therapy in Sub-Saharan Africa: A Cohort-Based Modelling Study

Using data from the ARROW trial, Joanna Lewis and colleagues investigate the CD4 cell count recovery profiles of children infected with HIV starting antiretroviral therapy in Sub-Saharan Africa. Please see later in the article for the Editors' Summary

[1]  Arrow trial team.  Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial , 2013 .

[2]  R. Callard,et al.  Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution. , 2012, The Journal of infectious diseases.

[3]  P. Phanuphak,et al.  Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries , 2011, Current opinion in HIV and AIDS.

[4]  J. Meigs,et al.  Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare System , 2010, Journal of acquired immune deficiency syndromes.

[5]  J. Chmiel,et al.  Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Hughes,et al.  Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children , 2010, AIDS.

[7]  M. Pujades-Rodriguez,et al.  Antiretroviral Therapy Outcomes in Resource-Limited Settings for HIV-Infected Children <5 Years of Age , 2010, Pediatrics.

[8]  A. Breckenridge,et al.  Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial , 2010, The Lancet.

[9]  M. Guiguet,et al.  Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. , 2009, The Lancet. Oncology.

[10]  Ross J. Harris,et al.  Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements , 2009, AIDS.

[11]  Robin Callard,et al.  Quantifying Thymic Export: Combining Models of Naive T Cell Proliferation and TCR Excision Circle Dynamics Gives an Explicit Measure of Thymic Output1 , 2009, The Journal of Immunology.

[12]  R. Écochard,et al.  CD4 Cell Response Before and After HAART Initiation According to Viral Load and Growth Indicators in HIV-1-Infected Children in Abidjan, Côte d'Ivoire , 2008, Journal of acquired immune deficiency syndromes.

[13]  W. Moss,et al.  Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. , 2008, The Lancet. Infectious diseases.

[14]  A. d’Arminio Monforte,et al.  Response to combination antiretroviral therapy: variation by age , 2008, AIDS.

[15]  K. Bochennek,et al.  Age‐matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis , 2008, European journal of haematology.

[16]  Paige L. Williams,et al.  Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  C. Rouzioux,et al.  Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens , 2006, AIDS.

[18]  E. Ruiz-Mateos,et al.  Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy , 2006, BMC infectious diseases.

[19]  H. Jacqmin-Gadda,et al.  Determinants of response to first HAART regimen in antiretroviral‐naïve patients with an estimated time since HIV seroconversion , 2006, HIV medicine.

[20]  A. Walker,et al.  Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study , 2004, AIDS.

[21]  H. Jacqmin-Gadda,et al.  Bivariate Longitudinal Model For The Analysis Of The Evolution Of Hiv Rna And Cd4 Cell Count In Hiv Infection Taking Into Account Left Censoring Of Hiv Rna Measures , 2003, Journal of biopharmaceutical statistics.

[22]  F. Mascart,et al.  Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children , 2003, The Pediatric infectious disease journal.

[23]  S. Sánchez-Ramón,et al.  Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS. , 2002, AIDS research and human retroviruses.

[24]  N. Klein,et al.  Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. , 2002, The Journal of infectious diseases.

[25]  H. Hooijkaas,et al.  Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status , 2001, AIDS.

[26]  N. Klein,et al.  Immune repopulation after HAART in previously untreated HIV-1-infected children , 2000, The Lancet.

[27]  R. Nelson,et al.  Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages. , 1999, The Journal of pediatrics.

[28]  T J Cole,et al.  British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. , 1998, Statistics in medicine.

[29]  Rob J. De Boer,et al.  Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation , 1998, Nature Medicine.

[30]  A E Ades,et al.  Age-related reference ranges: significance tests for models and confidence intervals for centiles. , 1994, Statistics in medicine.

[31]  T. Reichert,et al.  Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. , 1994, Clinical immunology and immunopathology.

[32]  V. Deneys,et al.  Age-related changes in human blood lymphocyte subpopulations. , 1992, The Journal of pediatrics.

[33]  H. Müller-Hermelink,et al.  The Involution of the Ageing Human Thymic Epithelium is Independent of Puberty , 1985, Scandinavian journal of immunology.

[34]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[35]  J. Amo.  The Antiretroviral Therapy Cohort Collaboration (ART-CC) * , 2013 .